Long-Term Efficacy and Safety of Pegcetacoplan Over 36 Months: Results From 12 Months of the GALE Open-Label Extension Study_Jeffrey Heier

Access Resources

Long-Term Efficacy and Safety of Pegcetacoplan Over 36 Months: Results From 12 Months of the GALE Open-Label Extension Study_Charles C. Wykoff, et al.

Access Resources

Pegcetacoplan vs Avacincaptad Pegol in Patients With Geographic Atrophy: An Anchored Matching-Adjusted Indirect Comparison of Three Phase 3 Trials

Access Resources

Artificial Intelligence (AI) in the Management of Geographic Atrophy (GA)

Access Resources